2012 News

Guglielmo
Faculty retreat, Recent faculty publications: Burlingame, Arkin, Chen, Cocohoba, Bero. Recently received research funding: Yang, Ahituv, Wells, Burlingame. Gifts: John and Marcia Goldman Foundation: The Kidney Project, Harry W. Hind Request: Troy C. Daniels Distinguished Professorship, The Joseph and Vera Long Foundation: Mary Anne Koda-Kimble Seed Award for Innovation. PharmD students: Class of 2012 stats, SNPhA: Chang and Alvarez. PhD students: CCB: Miller and Serafimova.
Gartner
It can take just the flick of a genetic switch for breast cells to kick-start the normally well-regulated process of growth seen in puberty, pregnancy, or the menstrual cycle—or the mutation of that switch to initiate the unchecked proliferation of cancer.
Shu
Xiaokun Shu, PhD, has been named a recipient of the 2012 National Institutes of Health (NIH) Director’s New Innovator award, which will provide up to $1.5 million in research funding over the next five years. Shu, a faculty member in the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry, will use the funding to develop a new technology to identify dynamic interactions between proteins in human cells.
Guglielmo
Joseph Guglielmo, PharmD, has been named interim dean of the UCSF School of Pharmacy, and will take the reins of the school from outgoing Dean Mary Anne Koda-Kimble, PharmD, as of July 1. Guglielmo is an internationally recognized expert in the clinical use of antimicrobials and has served as chair of the Department of Clinical Pharmacy since 2006.
closeup of hand on laptop keyboard
New computer models were able to successfully predict negative side effects for hundreds of currently marketed drugs, report researchers from the UCSF School of Pharmacy, SeaChange Pharmaceuticals, and Novartis Institutes for Biomedical Research in a paper published online this week in the journal Nature.
Entamoeba histolytica in cyst form
The UCSF School of Pharmacy’s Small Molecule Discovery Center (SMDC) provided a key assist to researchers seeking to repurpose existing drugs to treat the worldwide scourge of amoebic dysentery.
Koda-Kimble
Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, was honored by the UCSF Medical Center on May 4, 2012 for her “exceptional vision as a leader, commitment to patients, compassion as a human being, and dedication to UCSF Medical Center and UCSF Benioff Children’s Hospital.” The leadership award is especially significant, according to Koda-Kimble, “because the Medical Center is at the heart of my career as a pharmacist.”
Hind
Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96. Hind co-founded Barnes-Hind Pharmaceuticals Inc., which developed drugs to treat tuberculosis and glaucoma. He was a trustee of the UCSF Foundation and a major benefactor of the School of Pharmacy.
Burlingame
From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.
chart
For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. Total grants and contracts awarded to School of Pharmacy researchers during the NIH fiscal year 2011 (running from October 1, 2010 to September 31, 2011) totaled $29.1 million, according to Michael Nordberg, MPA/HSA, associate dean of administration and finance.
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included two on-going projects by postdoctoral fellows: Improving computer programs to yield better drug candidates Ryan Coleman, PhD Post-doctoral fellow in the laboratory of Brian Shoichet, PhD Awarded an NIH fellowship of $48,398 in fiscal 2011, with an additional $52,190 of support in 2012
students in classroom
The UCSF School of Pharmacy continues to rank number 1 among Doctor of Pharmacy (PharmD) programs in the United States, according to a new, 2012 survey published by U.S. News & World Report. The survey results appear in the magazine’s 2013 issue of “American Best Graduate Schools,” which appeared online today at the U.S. News & World Report website and will be available at newsstands on April 3.
Koda-Kimble
Research: growth over past decade from $17.6 to 43.5 million, Apollonio, Roy, Wells, Center for Quantitative Pharmacology, Quantitative Biosciences Consortium. Faculty: DeGrado, Savic, James, Day, Rice, MacDougall, Fischbach, Huang. Students: Hluhanich, Frear, Gavrilova, Gayle, Tantipinichwong, Vuong, Etemadi. New appointments: Nordberg, Rhode. Medical Center: APeX, Brodowy, Laret. Proposal to UC Regents: Desmond-Hellmann, working group. Strategic plan.
Koda-Kimble
Following the UCSF website's announcement of School of Pharmacy Dean Mary Anne Koda-Kimble's June 30, 2012 retirement came comments from leaders at UCSF and beyond. Koda-Kimble, whose 46 years at UCSF began as a PharmD student, became (in 1998) the first female dean of the top-ranked pharmacy school in the nation and the first leader from a clinical background.
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, announced today that she is stepping down as dean and retiring from UCSF on June 30, 2012, after 14 years as dean and 41 years as a member of the faculty. “I am prouder than ever with the accomplishments of our staff, faculty, and students and more energized than ever by the possibilities for the School and UCSF in the coming years…now is an auspicious time for a new and visionary leader.”